SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15258790
Source:
http://linkedlifedata.com/resource/pubmed/id/15258790
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0027121
,
umls-concept:C0443252
,
umls-concept:C1274040
pubmed:issue
7
pubmed:dateCreated
2004-7-19
pubmed:abstractText
To determine the response to treatment and the long-term outcome of patients with the antisynthetase syndrome associated with anti-Jo-1-antibodies.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0423161
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Antinuclear
,
http://linkedlifedata.com/resource/pubmed/chemical/Histidine-tRNA Ligase
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulins, Intravenous
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Jo-1 antibody
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0340-5354
pubmed:author
pubmed-author:HautmannHubertH
,
pubmed-author:LeinsingerGerdaG
,
pubmed-author:Müller-FelberWolfgangW
,
pubmed-author:PongratzDieterD
,
pubmed-author:Schlotter-WeigelBeateB
,
pubmed-author:SchröderMiraM
,
pubmed-author:SpäthMichaelM
,
pubmed-author:WalterMaggie CMC
pubmed:issnType
Print
pubmed:volume
251
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
859-64
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:15258790-Adult
,
pubmed-meshheading:15258790-Aged
,
pubmed-meshheading:15258790-Antibodies, Antinuclear
,
pubmed-meshheading:15258790-Disease Progression
,
pubmed-meshheading:15258790-Female
,
pubmed-meshheading:15258790-Histidine-tRNA Ligase
,
pubmed-meshheading:15258790-Humans
,
pubmed-meshheading:15258790-Immunoglobulins, Intravenous
,
pubmed-meshheading:15258790-Immunosuppressive Agents
,
pubmed-meshheading:15258790-Lung
,
pubmed-meshheading:15258790-Lung Diseases, Interstitial
,
pubmed-meshheading:15258790-Male
,
pubmed-meshheading:15258790-Middle Aged
,
pubmed-meshheading:15258790-Muscle, Skeletal
,
pubmed-meshheading:15258790-Myositis
,
pubmed-meshheading:15258790-Survival Rate
,
pubmed-meshheading:15258790-Time Factors
,
pubmed-meshheading:15258790-Treatment Outcome
pubmed:year
2004
pubmed:articleTitle
The long-term outcome of anti-Jo-1-positive inflammatory myopathies.
pubmed:affiliation
Friedrich-Baur-Institut, Department of Neurology, University of Munich, Ziemssenstr. 1a, 80336, Germany.
pubmed:publicationType
Journal Article